Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is ...

LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.

Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...

Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...

Burlington, North Carolina Wednesday, March 12, 2025, 14:00 Hrs [IST] ...

The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.

The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.

Labcorp has entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...

Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for ...

Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...

WASHINGTON D.C. (February 25, 2025) – John Crowley, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after Representatives Gregory Murphy (R-NC), ...